Back to top

Image: Bigstock

Bartosiak: Trading Twitter's (TWTR) Earnings with Options

Read MoreHide Full Article

On Thursday, February 9th, Twitter will release its fourth quarter earnings results before the bell. The company is a Zacks Rank 3 (Hold), and have a Value, Growth, and Momentum score of C.

Dave will look at Twitter’s past earnings, take a look at what is currently going on with the company, and give us his thoughts on their upcoming earnings announcement.

Furthermore, Dave will uncover some potential options trades for investors looking to make a play on Twitter ahead of earnings.

Twitter in Focus

Twitter is a public, real-time, global platform where any user can create a Tweet and any user can follow other users. The platform is unique in its simplicity: Tweets are limited to 140 characters of text. This constraint makes it easy for anyone to quickly create, distribute and discover content that is consistent across our platform and optimized for mobile devices. As a result, Tweets drive a high velocity of information exchange that makes Twitter uniquely live.

Twitter is expected to report earnings at -$0.11 per share according to the Zacks Consensus Estimate. Last quarter they beat earnings expectations by 33.33%. They reported earnings at -$0.10 per share, beating their estimate of -$0.15. They have an average earnings surprise of 38.08%.

Twitter, Inc. Price, Consensus and EPS Surprise

Twitter, Inc. Price, Consensus and EPS Surprise | Twitter, Inc. Quote

Bottom Line

How should investors play Twitter ahead of their earnings report? For insights on the best options trades, then tune in at 1:00pm today to see David’s thoughts.

The Best & Worst of Zacks

Today you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buys" free of charge. From 1988 through 2015 this list has averaged a stellar gain of +26% per year. Plus, you may download 220 Zacks Rank #5 "Strong Sells." Even though this list holds many stocks that seem to be solid, it has historically performed 11X worse than the market. See these critical buys and sells free >>